Related Experiment Videos
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy
Matteo Dal Ferro1, Davide Stolfo1, Alessandro Altinier1
1Cardiovascular Department, Azienda Sanitaria-Universitaria Integrata of Trieste "ASUITS", Trieste, Italy.
Heart (British Cardiac Society)
|April 19, 2017
Summary
Genetic testing in dilated cardiomyopathy (DCM) identified variants in 57% of patients. Rare variants in structural cytoskeleton Z-disk genes were linked to reduced left ventricular reverse remodelling (LVRR) in DCM patients.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Basis of Cardiomyopathies
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure with a strong genetic component.
- Understanding the genetic architecture of DCM is crucial for diagnosis, prognosis, and potential therapeutic strategies.
- Left ventricular reverse remodelling (LVRR) is a key indicator of improved outcomes in DCM patients.
Purpose of the Study:
- To investigate the genetic landscape of a well-characterized DCM cohort using next-generation sequencing (NGS).
- To assess the relationship between distinct genotype groups and the occurrence of left ventricular reverse remodelling (LVRR).
- To explore the clinical implications of genotype-specific findings in DCM management.
Main Methods:
- A cohort of 152 DCM patients was analyzed using next-generation sequencing (NGS).
- Patients were categorized into 'gene-clusters' based on functional genetic similarities.
- LVRR was defined by improvements in left ventricular ejection fraction and dimensions over a 24-month follow-up period.
Main Results:
- Pathogenic variants were identified in 57% of DCM patients, with notable frequencies in TTN, LMNA, and structural cytoskeleton Z-disk genes.
- A significant association was observed between gene cluster subgroups and LVRR.
- Carriers of rare variants in structural cytoskeleton Z-disk genes exhibited a significantly lower rate of LVRR (6%) and were independently associated with reduced LVRR.
Conclusions:
- NGS provides a high diagnostic yield for identifying genetic causes of DCM.
- A functional 'gene-clusters' classification may aid in the clinical management of genetically determined DCM.
- Rare variants in structural cytoskeleton Z-disk genes are independently associated with a lower likelihood of LVRR in DCM patients.